The database records the following features of discontinued drugs for cardiovascular and metabolic diseases within the 2011-2021 time-window: ● drug name ● sponsor company ● genetic target (N/A for th
Background: More than 100 million Americans are living with metabolic syndrome, increasing their propensity to develop heart diseaseâ the leading cause of death worldwide. A major contributing facto
There is strong evidence indicating that gut microbiota have the potential to modify, or be modified by the drugs and nutritional interventions that we rely upon. This study aims to characterize the c
